{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:46:21Z","timestamp":1792007181660,"version":"4.4.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.seminoncol.2025.152343","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T07:59:10Z","timestamp":1744617550000},"page":"152343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Liquid biopsy: An innovative tool in oncology. Where do we stand?"],"prefix":"10.1016","volume":"52","author":[{"given":"Serafina","family":"Martella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demi","family":"Wekking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Lambertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pettinato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"Parrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Semonella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Maccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Scartozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Addeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Solinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seminoncol.2025.152343_bib0001","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1159\/000493969","article-title":"Liquid biopsy beyond circulating tumor cells and cell-free DNA","volume":"63","author":"Junqueira-Neto","year":"2019","journal-title":"Acta Cytol"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0002","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12943-019-1043-x","article-title":"Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA","volume":"18","author":"Ye","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0003","first-page":"11","article-title":"Cancer diagnosis: from tumor to liquid biopsy and beyond","volume":"19","author":"Vaidyanathan","year":"2018","journal-title":"Lab Chip"},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152343_bib0004","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.7150\/thno.18588","article-title":"Circulating tumor cells: moving biological insights into detection","volume":"7","author":"Chen","year":"2017","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152343_bib0005","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating liquid biopsies into the management of cancer","volume":"14","author":"Siravegna","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0006","doi-asserted-by":"crossref","unstructured":"Yap, T.A., Lorente, D., Omlin, A. et al. Circulating tumour cells: a multifunctional biomarker. Clin Cancer Res. 2014;20:2553\u201368.","DOI":"10.1158\/1078-0432.CCR-13-2664"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0007","doi-asserted-by":"crossref","unstructured":"Siravegna, G., Marsoni, S., Siena, S. et al. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017; 14(9):531\u201348.","DOI":"10.1038\/nrclinonc.2017.14"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0008","doi-asserted-by":"crossref","unstructured":"Alix-Panabi\u00e8res, C., Pantel, K. Technologies for detection of circulating tumor cells: facts and vision. Lab Chip. 2014;14(1):57\u201362.","DOI":"10.1039\/C3LC50644D"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0009","doi-asserted-by":"crossref","unstructured":"Lowe, A.C. Circulating tumor cells: applications in cytopathology. Surg Pathol Clin. 2018;11(3):679\u201386.","DOI":"10.1016\/j.path.2018.04.008"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0010","doi-asserted-by":"crossref","unstructured":"Pantel, K., Alix-Panabi\u00e8res, C. Functional studies on viable circulating tumor cells. Clin Chem. 2016;62(2):328\u201334.","DOI":"10.1373\/clinchem.2015.242537"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152343_bib0013","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1158\/0008-5472.CAN-15-0145","article-title":"Ex vivo culture of CTCs: an emerging resource to guide cancer therapy","volume":"75","author":"Maheswaran","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0014","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","article-title":"RNA-seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics","volume":"28","author":"Best","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0015","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1182\/blood-2011-03-344408","article-title":"Blood platelets contain tumor-derived RNA biomarkers","volume":"118","author":"Nilsson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0016","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0037-1606182","article-title":"Platelet RNA in cancer diagnostics","volume":"44","author":"Tjon-Kon-Fat","year":"2018","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152343_bib0017","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","article-title":"Rna-seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular path- way cancer diagnostics","volume":"28","author":"Best","year":"2015","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152343_bib0018","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/blood-2008-06-159541","article-title":"Platelets actively sequester angiogenesis regulators","volume":"113","author":"Klement","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152343_bib0019","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1752-8062.2010.00226.x","article-title":"Significant downregulation of platelet gene expression in metastatic lung cancer","volume":"3","author":"Calverley","year":"2010","journal-title":"Clin Transl Sci"},{"issue":"13","key":"10.1016\/j.seminoncol.2025.152343_bib0020","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1182\/blood-2011-03-344408","article-title":"Blood platelets contain tumor-derived RNA biomarkers","volume":"118","author":"Nilsson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0021","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0022","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jhbp.601","article-title":"Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patients","volume":"26","author":"Kawamura","year":"2019","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152343_bib0023","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/cells8070688","article-title":"Detection of AR-V7 in liquid biopsies of castrate resistant prostate cancer patients: a comparison of AR-V7 analysis in circulating tumor cells, circulating tumor RNA and exosomes","volume":"8","author":"Nimir","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0024","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.tig.2015.06.001","article-title":"Accessing genetic information with liquid biopsies","volume":"31","author":"Cai","year":"2015","journal-title":"Trends Genet"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152343_bib0025","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.annonc.2021.01.074","article-title":"Exosome-based liquid biopsies in cancer: opportunities and challenges","volume":"32","author":"Yu","year":"2021","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152343_bib0026","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","article-title":"Extracellular vesicles in cancer: cell-to-cell mediators of metastasis","volume":"30","author":"Becker","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152343_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21873\/cgp.20015","article-title":"The multiple roles of exosomes in metastasis","volume":"14","author":"Weidle","year":"2017","journal-title":"Cancer Genomics Proteomics"},{"issue":"21","key":"10.1016\/j.seminoncol.2025.152343_bib0028","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1039\/C7LC00592J","article-title":"Microfluidics for exosome isolation and analysis: enabling liquid biopsy for personalized medicine","volume":"17","author":"Contreras-Naranjo","year":"2017","journal-title":"Lab Chip"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152343_bib0029","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2014.03.007","article-title":"Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis","volume":"25","author":"Zhou","year":"2014","journal-title":"Cancer Cell"},{"issue":"22","key":"10.1016\/j.seminoncol.2025.152343_bib0030","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1038\/onc.2012.295","article-title":"Leukemia cell to endothelial cell communication via exosomal miRNAs","volume":"32","author":"Umezu","year":"2013","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152343_bib0031","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ijc.30669","article-title":"The role of exosomes and miRNAs in drug-resistance of cancer cells","volume":"141","author":"Bach","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0032","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.canlet.2018.02.002","article-title":"Exosomal microRNAs (exomiRs): small molecules with a big role in cancer","volume":"420","author":"Bhome","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0033","article-title":"Diagnostic technologies for circulating tumour cells and exosomes","volume":"36","author":"Shao","year":"2015","journal-title":"Biosci Rep"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152343_bib0034","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct Target Ther"},{"issue":"32","key":"10.1016\/j.seminoncol.2025.152343_bib0036","doi-asserted-by":"crossref","first-page":"32774","DOI":"10.18632\/oncotarget.5192","article-title":"MiR-134 in extracellular vesicles reduces triplenegative breast cancer aggression and increases drug sensitivity","volume":"6","author":"O'Brien","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152343_bib0037","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1002\/jcp.26481","article-title":"Exosomal miRNAs as novel cancer biomarkers: challenges and opportunities","volume":"233","author":"Salehi","year":"2018","journal-title":"J Cell Physiol"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152343_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201069","article-title":"Quantification of microRNA levels in plasma - impact of preanalytical and analytical conditions","volume":"13","author":"Binderup","year":"2018","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.seminoncol.2025.152343_bib0039","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.7150\/thno.34443","article-title":"SDH5 depletion enhances radiosensitivity by regulating p53: a new method for noninvasive prediction of radiotherapy response","volume":"9","author":"Zong","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0040","first-page":"33","article-title":"Detection of low frequency FGFR3 mutations in the urine of bladder cancer patients using next-generation deep sequencing","volume":"4","author":"Millholland","year":"2012","journal-title":"Res Rep Urol"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152343_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002199","article-title":"Base-position error rate analysis of next-generation sequencing applied to circulating tumor DNA in non-small cell lung cancer: a prospective study","volume":"13","author":"P\u00e9cuchet","year":"2016","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152343_bib0045","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/annonc\/mdy061","article-title":"RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study","volume":"29","author":"Bachet","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0046","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.omto.2021.06.016","article-title":"Systematic review of the tableslogical landscape of Wilms tumors","volume":"22","author":"Palmisani","year":"2021","journal-title":"Mol Ther Oncolytics"},{"issue":"224","key":"10.1016\/j.seminoncol.2025.152343_bib0047","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in earlyand late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"issue":"18","key":"10.1016\/j.seminoncol.2025.152343_bib0048","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1093\/nar\/gkq421","article-title":"Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts","volume":"38","author":"Thierry","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"10.1016\/j.seminoncol.2025.152343_bib0049","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1158\/1078-0432.CCR-17-0510","article-title":"Clinical implications of monitoring circulating tumor DNA in patients with colorectal cancer","volume":"23","author":"Scholer","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.omtn.2020.01.035","article-title":"Targeting circulating SINEs and LINEs with DNase I provides metastases inhibition in experimental tumor models","volume":"20","author":"Alekseeva","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1-2","key":"10.1016\/j.seminoncol.2025.152343_bib0052","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000473882","article-title":"Liquid biopsies for monitoring temporal genomic heterogeneity in breast and colon cancers","volume":"85","author":"Venesio","year":"2018","journal-title":"Pathobiology"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0053","doi-asserted-by":"crossref","first-page":"9236","DOI":"10.1073\/pnas.96.16.9236","volume":"96","author":"Vogelstein","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0054","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3892\/etm.2015.2221","article-title":"Comparison of droplet digital PCR and conventional quantitative PCR for measuring EGFR gene mutation","volume":"9","author":"Zhang","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0055","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/jclinpath-2015-203429","article-title":"EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: a validation study","volume":"69","author":"Malapelle","year":"2016","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2019.101480","article-title":"Technical progress in circulating tumor DNA analysis using next generation sequencing","volume":"49","author":"Bai","year":"2020","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0057","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-genom-083115-022413","article-title":"Advancements in next-generation sequencing","volume":"17","author":"Levy","year":"2016","journal-title":"Annu Rev Genom Hum Genet."},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152343_bib0058","first-page":"123","article-title":"Sequencing technologies: introduction and applications","volume":"19","author":"Srivastava","year":"2019","journal-title":"Int. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152343_bib0063","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jtho.2021.06.017","article-title":"Liquid biopsy for advanced NSCLC: a consensus statement from the International Association for the Study of Lung Cancer","volume":"16","author":"Rolfo","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152343_bib0064","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001504","article-title":"Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab based therapy in non-small cell lung cancer (NSCLC)","volume":"9","author":"Ricciuti","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0065","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2052410","article-title":"Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting","volume":"11","author":"Kato","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0068","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.7150\/thno.34070","article-title":"Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer","volume":"9","author":"Tong","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0069","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3324\/haematol.2019.241208","article-title":"Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas","volume":"106","author":"Bobillo","year":"2021","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152343_bib0070","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/cas.16097","article-title":"Beyond blood: advancing the frontiers of liquid biopsy in oncology and personalized medicine","volume":"115","author":"Bao","year":"2024","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152343_bib0073","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00268-9","article-title":"Screening and predicted value of potential biomarkers for breast cancer using bioinformatics analysis","volume":"11","author":"Zeng","year":"2021","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.seminoncol.2025.152343_bib0074","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1158\/1078-0432.CCR-23-3321","article-title":"Measurement of ctDNA tumor fraction identifies informative negative liquid biopsy results and informs value of tissue confirmation","volume":"30","author":"Rolfo","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152343_bib0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41467-020-20162-8","article-title":"Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104619","article-title":"Role of the International Society of Liquid Biopsy (ISLB) in establishing quality control frameworks for clinical integration","author":"Fusco","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152343_bib0077","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1634\/theoncologist.2016-0082","article-title":"Clinical utility of liquid diagnostic platforms in non-small cell lung cancer","volume":"21","author":"Levy","year":"2016","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152343_bib0078","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3233\/CBM-181511","article-title":"Comparison of circulating DNA from plasma and urine for EGFR mutations in NSCLC patients","volume":"23","author":"Zhang","year":"2018","journal-title":"Cancer Biomark"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152343_bib0079","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jmoldx.2023.09.004","article-title":"Recommendations for cell-free DNA assay validations: a joint consensus recommendation of the Association for Molecular Pathology and College of American Pathologists","volume":"25","author":"Lockwood","year":"2023","journal-title":"J Mol Diagn"},{"issue":"7957","key":"10.1016\/j.seminoncol.2025.152343_bib0080","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-023-05776-4","article-title":"Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA","volume":"616","author":"Abbosh","year":"2023","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152343_bib0081","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1111\/cas.14926","article-title":"CIRCULATE-Japan: circulating tumor DNA-guided adaptive platform trials to refine adjuvant therapy for colorectal cancer","volume":"112","author":"Taniguchi","year":"2021","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152343_bib0082","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41591-022-02115-4","article-title":"Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer","volume":"29","author":"Kotani","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152343_bib0083","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clcc.2022.12.001","article-title":"Molecular residual disease-guided adjuvant treatment in resected colorectal cancer: focus on CIRCULATE-Japan","volume":"22","author":"Sato","year":"2023","journal-title":"Clin Colorectal Cancer"},{"issue":"10409","key":"10.1016\/j.seminoncol.2025.152343_bib0084","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0140-6736(23)01700-2","article-title":"Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study","volume":"402","author":"Schrag","year":"2023","journal-title":"Lancet"},{"issue":"6378","key":"10.1016\/j.seminoncol.2025.152343_bib0085","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.seminoncol.2025.152343_bib0086","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1158\/1940-6207.CAPR-24-0107","article-title":"Multiyear clinical outcomes of cancers diagnosed following detection by a blood-based multicancer early detection test","volume":"17","author":"Buchanan","year":"2024","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0087","doi-asserted-by":"crossref","unstructured":"Advancing cancer screening with liquid biopsies. Cancer Discov. 2018;8(3):256.","DOI":"10.1158\/2159-8290.CD-NB2018-009"},{"issue":"28","key":"10.1016\/j.seminoncol.2025.152343_bib0088","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.3748\/wjg.v23.i28.5086","article-title":"Colorectal cancer screening: an updated review of the available options","volume":"23","author":"Issa","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152343_bib0089","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000507701","article-title":"Non-invasive colorectal cancer screening: an overview","volume":"7","author":"Tepus","year":"2020","journal-title":"Gastrointest Tumors"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152343_bib0090","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s40291-020-00473-8","article-title":"Epi proColon\u00ae for colorectal cancer screening: A profile of its use in the USA","volume":"24","author":"Shirley","year":"2020","journal-title":"Mol Diagn Ther"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152343_bib0091","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237802","article-title":"Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin","volume":"15","author":"Woodhouse","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152343_bib0092","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1080\/13696998.2024.2413289","article-title":"Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis","volume":"27","author":"Isla","year":"2024","journal-title":"J Med Econ"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0093","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1200\/EDBK_199765","article-title":"Liquid biopsy to identify actionable genomic alterations","volume":"38","author":"Ou","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0094","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1056\/NEJMoa1716078","article-title":"Neoadjuvant PD-1 blockade in resectable lung cancer","volume":"378","author":"Forde","year":"2018","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.seminoncol.2025.152343_bib0095","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1158\/1078-0432.CCR-18-3663","article-title":"Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence","volume":"25","author":"Coombes","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152343_bib0096","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005924","article-title":"Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy","volume":"11","author":"Sivapalan","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152343_bib0097","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ijc.33217","article-title":"Liquid biopsies: potential and challenges","volume":"148","author":"Heidrich","year":"2021","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152343_bib0098","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152343_bib0099","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1158\/2159-8290.CD-15-1483","article-title":"Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy","volume":"6","author":"Alix-Panabi\u00e8res","year":"2016","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152343_bib0100","article-title":"The Liquid Biopsy Consortium: challenges and opportunities for early cancer detection and monitoring","volume":"4","author":"Batool","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.seminoncol.2025.152343_bib0101","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2019.12.007","article-title":"Artificial intelligence in cancer diagnosis and prognosis: opportunities and challenges","volume":"471","author":"Huang","year":"2020","journal-title":"Cancer Lett"},{"issue":"D1","key":"10.1016\/j.seminoncol.2025.152343_bib0102","doi-asserted-by":"crossref","first-page":"D900","DOI":"10.1093\/nar\/gky939","article-title":"CancerSEA: a cancer single-cell state atlas","volume":"47","author":"Yuan","year":"2019","journal-title":"Nucleic Acids Res"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T10:01:21Z","timestamp":1746180081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775425000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0093775425000259"],"URL":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152343","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid biopsy: An innovative tool in oncology. Where do we stand?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152343"}}